299 related articles for article (PubMed ID: 34981193)
1. Dual-specificity phosphatases: therapeutic targets in cancer therapy resistance.
Zandi Z; Kashani B; Alishahi Z; Pourbagheri-Sigaroodi A; Esmaeili F; Ghaffari SH; Bashash D; Momeny M
J Cancer Res Clin Oncol; 2022 Jan; 148(1):57-70. PubMed ID: 34981193
[TBL] [Abstract][Full Text] [Related]
2. Targeted Inhibition of the Dual Specificity Phosphatases DUSP1 and DUSP6 Suppress MPNST Growth via JNK.
Ramkissoon A; Chaney KE; Milewski D; Williams KB; Williams RL; Choi K; Miller A; Kalin TV; Pressey JG; Szabo S; Azam M; Largaespada DA; Ratner N
Clin Cancer Res; 2019 Jul; 25(13):4117-4127. PubMed ID: 30936125
[TBL] [Abstract][Full Text] [Related]
3. Differential expression profiles and roles of inducible DUSPs and ERK1/2-specific constitutive DUSP6 and DUSP7 in microglia.
Ham JE; Oh EK; Kim DH; Choi SH
Biochem Biophys Res Commun; 2015 Nov; 467(2):254-60. PubMed ID: 26435497
[TBL] [Abstract][Full Text] [Related]
4. Spatiotemporal regulation of ERK2 by dual specificity phosphatases.
Caunt CJ; Armstrong SP; Rivers CA; Norman MR; McArdle CA
J Biol Chem; 2008 Sep; 283(39):26612-23. PubMed ID: 18650424
[TBL] [Abstract][Full Text] [Related]
5. Dual-specificity MAP kinase phosphatases as targets of cancer treatment.
Nunes-Xavier C; Romá-Mateo C; Ríos P; Tárrega C; Cejudo-Marín R; Tabernero L; Pulido R
Anticancer Agents Med Chem; 2011 Jan; 11(1):109-32. PubMed ID: 21288197
[TBL] [Abstract][Full Text] [Related]
6. USP49 inhibits ischemia-reperfusion-induced cell viability suppression and apoptosis in human AC16 cardiomyocytes through DUSP1-JNK1/2 signaling.
Zhang W; Zhang Y; Zhang H; Zhao Q; Liu Z; Xu Y
J Cell Physiol; 2019 May; 234(5):6529-6538. PubMed ID: 30246457
[TBL] [Abstract][Full Text] [Related]
7. Gonadotropin-releasing hormone and protein kinase C signaling to ERK: spatiotemporal regulation of ERK by docking domains and dual-specificity phosphatases.
Armstrong SP; Caunt CJ; McArdle CA
Mol Endocrinol; 2009 Apr; 23(4):510-9. PubMed ID: 19179479
[TBL] [Abstract][Full Text] [Related]
8. A Crosstalk Between Dual-Specific Phosphatases and Dual-Specific Protein Kinases Can Be A Potential Therapeutic Target for Anti-cancer Therapy.
Celtikci B
Adv Exp Med Biol; 2021; 1275():357-382. PubMed ID: 33539023
[TBL] [Abstract][Full Text] [Related]
9. Regulation of angiopoietin-1/Tie-2 receptor signaling in endothelial cells by dual-specificity phosphatases 1, 4, and 5.
Echavarria R; Hussain SN
J Am Heart Assoc; 2013 Dec; 2(6):e000571. PubMed ID: 24308939
[TBL] [Abstract][Full Text] [Related]
10. Dual specific phosphatases (DUSPs) in cardiac hypertrophy and failure.
Mutlak M; Kehat I
Cell Signal; 2021 Aug; 84():110033. PubMed ID: 33933582
[TBL] [Abstract][Full Text] [Related]
11. A Tumor Cell-Selective Inhibitor of Mitogen-Activated Protein Kinase Phosphatases Sensitizes Breast Cancer Cells to Lymphokine-Activated Killer Cell Activity.
Kaltenmeier CT; Vollmer LL; Vernetti LA; Caprio L; Davis K; Korotchenko VN; Day BW; Tsang M; Hulkower KI; Lotze MT; Vogt A
J Pharmacol Exp Ther; 2017 Apr; 361(1):39-50. PubMed ID: 28154014
[TBL] [Abstract][Full Text] [Related]
12. Dual-specificity phosphatases: critical regulators with diverse cellular targets.
Patterson KI; Brummer T; O'Brien PM; Daly RJ
Biochem J; 2009 Mar; 418(3):475-89. PubMed ID: 19228121
[TBL] [Abstract][Full Text] [Related]
13. CD40-modulated dual-specificity phosphatases MAPK phosphatase (MKP)-1 and MKP-3 reciprocally regulate Leishmania major infection.
Srivastava N; Sudan R; Saha B
J Immunol; 2011 May; 186(10):5863-72. PubMed ID: 21471446
[TBL] [Abstract][Full Text] [Related]
14. Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W; Pew T; Zou M; Pang D; Conzen SD
J Biol Chem; 2005 Feb; 280(6):4117-24. PubMed ID: 15590693
[TBL] [Abstract][Full Text] [Related]
15. VEGF autoregulates its proliferative and migratory ERK1/2 and p38 cascades by enhancing the expression of DUSP1 and DUSP5 phosphatases in endothelial cells.
Bellou S; Hink MA; Bagli E; Panopoulou E; Bastiaens PI; Murphy C; Fotsis T
Am J Physiol Cell Physiol; 2009 Dec; 297(6):C1477-89. PubMed ID: 19741200
[TBL] [Abstract][Full Text] [Related]
16. Comparative analysis of dual specificity protein phosphatase genes 1, 2 and 5 in response to immune challenges in Japanese flounder Paralichthys olivaceus.
Li S; Hao G; Li J; Peng W; Geng X; Sun J
Fish Shellfish Immunol; 2017 Sep; 68():368-376. PubMed ID: 28743632
[TBL] [Abstract][Full Text] [Related]
17. Dexamethasone suppresses monocyte chemoattractant protein-1 production via mitogen activated protein kinase phosphatase-1 dependent inhibition of Jun N-terminal kinase and p38 mitogen-activated protein kinase in activated rat microglia.
Zhou Y; Ling EA; Dheen ST
J Neurochem; 2007 Aug; 102(3):667-78. PubMed ID: 17403137
[TBL] [Abstract][Full Text] [Related]
18. MAPK pathways regulation by DUSP1 in the development of osteosarcoma: Potential markers and therapeutic targets.
Lopes LJS; Tesser-Gamba F; Petrilli AS; de Seixas Alves MT; Garcia-Filho RJ; Toledo SRC
Mol Carcinog; 2017 Jun; 56(6):1630-1641. PubMed ID: 28112450
[TBL] [Abstract][Full Text] [Related]
19. Docosahexaenoic acid induces apoptosis in lung cancer cells by increasing MKP-1 and down-regulating p-ERK1/2 and p-p38 expression.
Serini S; Trombino S; Oliva F; Piccioni E; Monego G; Resci F; Boninsegna A; Picci N; Ranelletti FO; Calviello G
Apoptosis; 2008 Sep; 13(9):1172-83. PubMed ID: 18679798
[TBL] [Abstract][Full Text] [Related]
20. Dual-Specificity Phosphatase Regulation in Neurons and Glial Cells.
Pérez-Sen R; Queipo MJ; Gil-Redondo JC; Ortega F; Gómez-Villafuertes R; Miras-Portugal MT; Delicado EG
Int J Mol Sci; 2019 Apr; 20(8):. PubMed ID: 31018603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
